Litcius/Paper detail

Potent adjuvant effect elicited for tumor immunotherapy by a liposome conjugated pH-sensitive polymer and dendritic cell-targeting Toll-like-receptor ligand

Shun‐ichi Watanabe, Eiji Yuba, Takashi Akazawa, Viskam Wijewardana, Yuka Kakihara, Ayaka Azuma, Kenji Hagimori, Ryoji Kanegi, Shingo Hatoya, Norimitsu Inoue, Toshio Inaba, Kikuya Sugiura

2022Vaccine14 citationsDOIOpen Access PDF

Topics & Concepts

AdjuvantAntigenImmunotherapyImmune systemDendritic cellCytotoxicityCancer immunotherapyAntigen presentationLiposomeCross-presentationImmunologyCancer vaccineImmunopotentiatorCancer researchBiologyT cellIn vitroBiochemistryImmunotherapy and Immune ResponsesRNA Interference and Gene DeliveryNanoplatforms for cancer theranostics
Potent adjuvant effect elicited for tumor immunotherapy by a liposome conjugated pH-sensitive polymer and dendritic cell-targeting Toll-like-receptor ligand | Litcius